Francine Mary Benes, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| gamma-Aminobutyric Acid | 38 | 2015 | 1121 | 5.000 |
Why?
|
| Schizophrenia | 81 | 2021 | 6882 | 4.940 |
Why?
|
| Glutamate Decarboxylase | 20 | 2017 | 245 | 3.990 |
Why?
|
| Hippocampus | 42 | 2018 | 3675 | 3.880 |
Why?
|
| Bipolar Disorder | 34 | 2018 | 5027 | 2.630 |
Why?
|
| Interneurons | 19 | 2018 | 577 | 2.330 |
Why?
|
| Gyrus Cinguli | 24 | 2008 | 1091 | 2.250 |
Why?
|
| Amygdala | 14 | 2012 | 1315 | 1.820 |
Why?
|
| Prefrontal Cortex | 18 | 2018 | 2147 | 1.730 |
Why?
|
| Pyramidal Cells | 17 | 2014 | 363 | 1.350 |
Why?
|
| Neurons | 35 | 2018 | 9338 | 1.170 |
Why?
|
| Dopamine | 15 | 2009 | 1591 | 1.140 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 137 | 1.100 |
Why?
|
| Neural Pathways | 22 | 2017 | 2972 | 0.960 |
Why?
|
| Receptors, Kainic Acid | 3 | 2012 | 88 | 0.910 |
Why?
|
| Postmortem Changes | 7 | 2016 | 126 | 0.770 |
Why?
|
| Limbic System | 7 | 2006 | 426 | 0.740 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2017 | 8301 | 0.740 |
Why?
|
| Receptors, Dopamine D1 | 5 | 2004 | 291 | 0.730 |
Why?
|
| CA2 Region, Hippocampal | 2 | 2017 | 21 | 0.730 |
Why?
|
| Picrotoxin | 7 | 2012 | 65 | 0.730 |
Why?
|
| Rats | 43 | 2018 | 24260 | 0.720 |
Why?
|
| GABA Antagonists | 5 | 2009 | 128 | 0.720 |
Why?
|
| Nerve Net | 8 | 2021 | 2174 | 0.690 |
Why?
|
| Models, Neurological | 8 | 2015 | 1774 | 0.670 |
Why?
|
| Frontal Lobe | 12 | 2014 | 1406 | 0.670 |
Why?
|
| Isoenzymes | 8 | 2007 | 1726 | 0.660 |
Why?
|
| Cerebral Cortex | 23 | 2010 | 5708 | 0.640 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 56 | 0.610 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 2916 | 0.610 |
Why?
|
| Cell Count | 15 | 2007 | 1856 | 0.580 |
Why?
|
| Receptors, GABA-A | 8 | 2009 | 627 | 0.530 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2008 | 895 | 0.530 |
Why?
|
| Receptors, GABA | 6 | 2006 | 288 | 0.510 |
Why?
|
| Dendrites | 9 | 2018 | 485 | 0.510 |
Why?
|
| DNA Fragmentation | 2 | 2007 | 242 | 0.500 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 12072 | 0.480 |
Why?
|
| Haloperidol | 6 | 2014 | 397 | 0.480 |
Why?
|
| Glutamic Acid | 6 | 2009 | 1169 | 0.480 |
Why?
|
| Disease Models, Animal | 15 | 2018 | 18029 | 0.470 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 9438 | 0.470 |
Why?
|
| Diagnosis | 1 | 2014 | 154 | 0.470 |
Why?
|
| Myelin Sheath | 4 | 2004 | 652 | 0.450 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5853 | 0.450 |
Why?
|
| Dendritic Spines | 1 | 2014 | 233 | 0.450 |
Why?
|
| Serotonin | 3 | 2005 | 1017 | 0.440 |
Why?
|
| Brain | 22 | 2018 | 26385 | 0.430 |
Why?
|
| DNA Repair | 3 | 2010 | 2046 | 0.420 |
Why?
|
| Raphe Nuclei | 2 | 2005 | 104 | 0.410 |
Why?
|
| Neuroglia | 7 | 2005 | 927 | 0.400 |
Why?
|
| Schizophrenic Psychology | 7 | 1997 | 1678 | 0.380 |
Why?
|
| Synapses | 10 | 2008 | 1728 | 0.380 |
Why?
|
| Nerve Fibers | 4 | 1999 | 687 | 0.370 |
Why?
|
| Axons | 9 | 1994 | 1684 | 0.360 |
Why?
|
| Apoptosis | 5 | 2008 | 9727 | 0.350 |
Why?
|
| Neuronal Plasticity | 5 | 2009 | 1422 | 0.340 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1152 | 0.340 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 957 | 0.340 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 1999 | 375 | 0.330 |
Why?
|
| Animals | 60 | 2018 | 168757 | 0.330 |
Why?
|
| Artifacts | 1 | 2017 | 1904 | 0.320 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 497 | 0.320 |
Why?
|
| Gene Dosage | 2 | 2013 | 1252 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 5 | 2021 | 4462 | 0.320 |
Why?
|
| Antipsychotic Agents | 10 | 2015 | 3057 | 0.310 |
Why?
|
| RNA, Messenger | 14 | 2017 | 13033 | 0.310 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3647 | 0.300 |
Why?
|
| Molecular Chaperones | 3 | 2017 | 742 | 0.300 |
Why?
|
| Presynaptic Terminals | 4 | 2004 | 302 | 0.300 |
Why?
|
| Efferent Pathways | 1 | 2007 | 167 | 0.290 |
Why?
|
| Tissue Banks | 2 | 2010 | 184 | 0.290 |
Why?
|
| Cell Cycle | 3 | 2010 | 2967 | 0.290 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2007 | 156 | 0.290 |
Why?
|
| Electrophysiological Phenomena | 1 | 2008 | 315 | 0.290 |
Why?
|
| Infusion Pumps | 1 | 2007 | 163 | 0.280 |
Why?
|
| Entorhinal Cortex | 2 | 2000 | 272 | 0.280 |
Why?
|
| Receptors, Glutamate | 2 | 2017 | 232 | 0.270 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2008 | 178 | 0.260 |
Why?
|
| Cerebral Ventricles | 5 | 2013 | 544 | 0.260 |
Why?
|
| Nervous System Diseases | 3 | 2012 | 1622 | 0.260 |
Why?
|
| Ethology | 1 | 2004 | 7 | 0.250 |
Why?
|
| Co-Repressor Proteins | 2 | 2016 | 194 | 0.250 |
Why?
|
| DNA Methylation | 2 | 2018 | 4286 | 0.250 |
Why?
|
| Biogenic Monoamines | 1 | 2004 | 50 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 417 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.240 |
Why?
|
| Humans | 106 | 2021 | 744343 | 0.240 |
Why?
|
| Aging | 6 | 2007 | 8664 | 0.230 |
Why?
|
| Psychotic Disorders | 6 | 2010 | 3046 | 0.220 |
Why?
|
| Electrophysiology | 4 | 2012 | 1308 | 0.210 |
Why?
|
| Mental Disorders | 7 | 2016 | 6600 | 0.210 |
Why?
|
| CpG Islands | 2 | 2018 | 1172 | 0.210 |
Why?
|
| Benzazepines | 3 | 2000 | 326 | 0.210 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 574 | 0.210 |
Why?
|
| Human Experimentation | 1 | 2003 | 127 | 0.210 |
Why?
|
| Immunohistochemistry | 11 | 2012 | 11366 | 0.210 |
Why?
|
| Male | 59 | 2018 | 350118 | 0.200 |
Why?
|
| Catheterization | 1 | 2007 | 1470 | 0.200 |
Why?
|
| Dopamine Antagonists | 2 | 2000 | 296 | 0.200 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1995 | 475 | 0.200 |
Why?
|
| Autoradiography | 6 | 2008 | 745 | 0.190 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 354 | 0.190 |
Why?
|
| Neuropharmacology | 1 | 2001 | 21 | 0.190 |
Why?
|
| Glutamates | 2 | 1992 | 398 | 0.190 |
Why?
|
| Temporal Lobe | 4 | 2018 | 1670 | 0.190 |
Why?
|
| Parvalbumins | 2 | 2017 | 250 | 0.190 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 970 | 0.180 |
Why?
|
| Oligodendroglia | 1 | 2004 | 517 | 0.180 |
Why?
|
| Corticosterone | 1 | 2001 | 310 | 0.180 |
Why?
|
| Clozapine | 2 | 2014 | 498 | 0.180 |
Why?
|
| Models, Biological | 3 | 2012 | 9583 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2003 | 369 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4042 | 0.170 |
Why?
|
| Gene Expression | 7 | 2018 | 7799 | 0.170 |
Why?
|
| In Situ Hybridization | 4 | 2004 | 1950 | 0.160 |
Why?
|
| Alzheimer Disease | 7 | 2004 | 8037 | 0.160 |
Why?
|
| Lysine | 1 | 2002 | 1007 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7880 | 0.150 |
Why?
|
| Rats, Inbred Strains | 7 | 1994 | 2186 | 0.150 |
Why?
|
| Case-Control Studies | 7 | 2015 | 21746 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4751 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 1222 | 0.150 |
Why?
|
| Neocortex | 1 | 2001 | 400 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2015 | 6365 | 0.140 |
Why?
|
| Cytochromes c1 | 1 | 2016 | 8 | 0.140 |
Why?
|
| Atrophy | 6 | 2014 | 1583 | 0.140 |
Why?
|
| Phenotype | 5 | 2013 | 16365 | 0.140 |
Why?
|
| Neurons, Afferent | 3 | 2012 | 506 | 0.140 |
Why?
|
| Aged | 31 | 2018 | 163280 | 0.140 |
Why?
|
| Middle Aged | 33 | 2018 | 213383 | 0.140 |
Why?
|
| Informed Consent | 1 | 2003 | 995 | 0.140 |
Why?
|
| Aged, 80 and over | 13 | 2018 | 57776 | 0.130 |
Why?
|
| MSX1 Transcription Factor | 1 | 2015 | 53 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 2 | 2009 | 165 | 0.130 |
Why?
|
| Cyclin D2 | 1 | 2015 | 101 | 0.130 |
Why?
|
| Adult | 33 | 2016 | 214055 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2007 | 3002 | 0.130 |
Why?
|
| Varicose Veins | 1 | 1996 | 154 | 0.120 |
Why?
|
| Action Potentials | 2 | 2015 | 1806 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3920 | 0.120 |
Why?
|
| Substantia Nigra | 2 | 2008 | 353 | 0.120 |
Why?
|
| Nerve Endings | 1 | 1994 | 109 | 0.120 |
Why?
|
| Female | 36 | 2018 | 380194 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1676 | 0.120 |
Why?
|
| Cadaver | 3 | 2006 | 1337 | 0.120 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2373 | 0.110 |
Why?
|
| Cell Communication | 2 | 2005 | 1621 | 0.110 |
Why?
|
| Long-Term Potentiation | 2 | 2006 | 293 | 0.110 |
Why?
|
| Amyloid | 4 | 1991 | 795 | 0.100 |
Why?
|
| Biogenic Amines | 1 | 1991 | 50 | 0.100 |
Why?
|
| Microscopy, Electron | 6 | 2002 | 2645 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 1061 | 0.100 |
Why?
|
| Kainic Acid | 1 | 2012 | 199 | 0.100 |
Why?
|
| Microdissection | 2 | 2008 | 152 | 0.100 |
Why?
|
| Oscillometry | 1 | 2012 | 147 | 0.100 |
Why?
|
| RNA | 2 | 2016 | 2749 | 0.100 |
Why?
|
| Autopsy | 5 | 2010 | 1020 | 0.100 |
Why?
|
| Dentate Gyrus | 2 | 2004 | 160 | 0.100 |
Why?
|
| Receptors, Cholinergic | 2 | 2005 | 238 | 0.100 |
Why?
|
| Intermediate Filament Proteins | 3 | 1988 | 269 | 0.100 |
Why?
|
| Arousal | 1 | 1997 | 1165 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2018 | 23403 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1790 | 0.100 |
Why?
|
| Brain Damage, Chronic | 1 | 1991 | 265 | 0.090 |
Why?
|
| Reference Values | 4 | 2006 | 4982 | 0.090 |
Why?
|
| Thalamus | 1 | 1997 | 1023 | 0.090 |
Why?
|
| Cerebellum | 1 | 2018 | 1488 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 898 | 0.090 |
Why?
|
| Neurofibrils | 2 | 1990 | 76 | 0.090 |
Why?
|
| Neuropsychiatry | 1 | 2010 | 55 | 0.090 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 625 | 0.090 |
Why?
|
| Neurotransmitter Agents | 3 | 2008 | 647 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 964 | 0.090 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2009 | 67 | 0.090 |
Why?
|
| Genome | 1 | 2018 | 1808 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2016 | 5179 | 0.080 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2008 | 62 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1996 | 2505 | 0.080 |
Why?
|
| Brain Mapping | 3 | 2012 | 6669 | 0.080 |
Why?
|
| Animals, Newborn | 3 | 2005 | 2726 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1572 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 4 | 1996 | 1799 | 0.080 |
Why?
|
| Biological Specimen Banks | 1 | 2013 | 711 | 0.080 |
Why?
|
| Cerebral Ventriculography | 2 | 1990 | 44 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 604 | 0.080 |
Why?
|
| Rosaniline Dyes | 1 | 2007 | 51 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 1993 | 2699 | 0.080 |
Why?
|
| Research Design | 2 | 1998 | 5987 | 0.080 |
Why?
|
| Weaning | 2 | 1998 | 105 | 0.070 |
Why?
|
| Lasers | 1 | 1991 | 952 | 0.070 |
Why?
|
| Disaster Planning | 1 | 2013 | 549 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2003 | 3309 | 0.070 |
Why?
|
| Cohort Studies | 6 | 2018 | 40561 | 0.070 |
Why?
|
| Tritium | 2 | 1998 | 745 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 1999 | 1157 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 2013 | 748 | 0.070 |
Why?
|
| Neural Inhibition | 2 | 2001 | 602 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 528 | 0.070 |
Why?
|
| Neurofilament Proteins | 4 | 1991 | 318 | 0.070 |
Why?
|
| Denervation | 2 | 2005 | 278 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2004 | 8949 | 0.070 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2005 | 24 | 0.070 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2005 | 33 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 240 | 0.070 |
Why?
|
| Sympatholytics | 1 | 2005 | 83 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2703 | 0.070 |
Why?
|
| Dominance, Cerebral | 1 | 2007 | 635 | 0.070 |
Why?
|
| Oxidopamine | 1 | 2005 | 169 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2008 | 1137 | 0.060 |
Why?
|
| Zoology | 1 | 2004 | 1 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7722 | 0.060 |
Why?
|
| Geese | 1 | 2004 | 19 | 0.060 |
Why?
|
| Age Factors | 6 | 2003 | 18370 | 0.060 |
Why?
|
| Muscimol | 2 | 1996 | 69 | 0.060 |
Why?
|
| Digoxigenin | 1 | 2004 | 26 | 0.060 |
Why?
|
| Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2004 | 2740 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 19229 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2007 | 959 | 0.060 |
Why?
|
| Cell Size | 2 | 1997 | 643 | 0.060 |
Why?
|
| Cholecystokinin | 1 | 2004 | 114 | 0.060 |
Why?
|
| Commodification | 1 | 2003 | 3 | 0.060 |
Why?
|
| Duty to Recontact | 1 | 2003 | 20 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 2002 | 1178 | 0.060 |
Why?
|
| Cell Line | 1 | 2017 | 15997 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 335 | 0.060 |
Why?
|
| Adolescent | 10 | 2016 | 85781 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 1998 | 20129 | 0.050 |
Why?
|
| Staining and Labeling | 3 | 1992 | 1100 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 10388 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 401 | 0.050 |
Why?
|
| Diagnostic Imaging | 3 | 2009 | 3507 | 0.050 |
Why?
|
| Amyloidosis | 1 | 1989 | 795 | 0.050 |
Why?
|
| Genetic Research | 1 | 2003 | 174 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 643 | 0.050 |
Why?
|
| Synaptic Vesicles | 2 | 1985 | 191 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1998 | 2327 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 1997 | 4245 | 0.050 |
Why?
|
| Injections | 1 | 2004 | 840 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2892 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 302 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2010 | 1563 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2001 | 554 | 0.050 |
Why?
|
| Nerve Tissue | 1 | 2001 | 79 | 0.050 |
Why?
|
| Nobel Prize | 1 | 2001 | 49 | 0.050 |
Why?
|
| Industry | 1 | 2003 | 365 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2007 | 2290 | 0.050 |
Why?
|
| Ownership | 1 | 2003 | 332 | 0.050 |
Why?
|
| Neuropil | 1 | 1999 | 30 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10943 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1989 | 2866 | 0.040 |
Why?
|
| Histocytochemistry | 3 | 1996 | 719 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2001 | 862 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2001 | 513 | 0.040 |
Why?
|
| Haplotypes | 1 | 2006 | 2779 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 1999 | 288 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1663 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2000 | 302 | 0.040 |
Why?
|
| Neuromuscular Junction | 2 | 1998 | 398 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 1985 | 1221 | 0.040 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 1998 | 24 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1998 | 80 | 0.040 |
Why?
|
| Coated Vesicles | 1 | 1998 | 24 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 1978 | 84 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1978 | 150 | 0.040 |
Why?
|
| Neurosciences | 1 | 2003 | 348 | 0.040 |
Why?
|
| Sweden | 1 | 2001 | 1345 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1998 | 374 | 0.040 |
Why?
|
| Commerce | 1 | 2003 | 592 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4740 | 0.040 |
Why?
|
| Archaeology | 1 | 1997 | 37 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1547 | 0.040 |
Why?
|
| Ventral Tegmental Area | 1 | 1998 | 142 | 0.040 |
Why?
|
| Receptors, Dopamine | 1 | 1998 | 295 | 0.040 |
Why?
|
| Computers | 2 | 1991 | 612 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2005 | 11483 | 0.040 |
Why?
|
| Mitochondria | 3 | 2008 | 3520 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2001 | 2408 | 0.040 |
Why?
|
| Acetylcholine | 1 | 1978 | 621 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1998 | 566 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3086 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6756 | 0.030 |
Why?
|
| Time Factors | 5 | 2007 | 40075 | 0.030 |
Why?
|
| Mianserin | 1 | 1995 | 52 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1996 | 6459 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 1998 | 25625 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 1997 | 439 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2775 | 0.030 |
Why?
|
| Cytoskeleton | 2 | 2008 | 1185 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2001 | 1534 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 1989 | 3748 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12797 | 0.030 |
Why?
|
| Sex Factors | 2 | 2001 | 10397 | 0.030 |
Why?
|
| Acyltransferases | 2 | 1973 | 294 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1988 | 2255 | 0.030 |
Why?
|
| RNA Stability | 1 | 2016 | 321 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2002 | 944 | 0.030 |
Why?
|
| Spiperone | 1 | 1993 | 31 | 0.030 |
Why?
|
| Child | 5 | 2007 | 77709 | 0.030 |
Why?
|
| Linear Models | 1 | 2004 | 5952 | 0.030 |
Why?
|
| Protein Binding | 1 | 2006 | 9386 | 0.030 |
Why?
|
| Fear | 1 | 2002 | 1440 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2003 | 2240 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1730 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
| Infant | 4 | 1998 | 35136 | 0.030 |
Why?
|
| Video Recording | 1 | 1998 | 949 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2013 | 183 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 1998 | 1970 | 0.030 |
Why?
|
| Phospholipids | 2 | 1973 | 784 | 0.030 |
Why?
|
| Singapore | 1 | 2013 | 295 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 218 | 0.030 |
Why?
|
| Child, Preschool | 4 | 1998 | 41006 | 0.030 |
Why?
|
| Antibodies | 1 | 2000 | 2460 | 0.030 |
Why?
|
| Iproniazid | 1 | 1991 | 8 | 0.030 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 894 | 0.030 |
Why?
|
| Phenothiazines | 1 | 1992 | 63 | 0.030 |
Why?
|
| Bicuculline | 1 | 1992 | 99 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 56430 | 0.030 |
Why?
|
| Family | 1 | 2003 | 3147 | 0.030 |
Why?
|
| Social Environment | 1 | 1997 | 1023 | 0.030 |
Why?
|
| Brain Stem | 1 | 1977 | 846 | 0.030 |
Why?
|
| Trigeminal Nerve | 1 | 1973 | 249 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1991 | 158 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2971 | 0.020 |
Why?
|
| Penetrance | 1 | 2013 | 381 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12208 | 0.020 |
Why?
|
| Cell Movement | 2 | 1993 | 5217 | 0.020 |
Why?
|
| Emotions | 1 | 2002 | 2661 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 3508 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6114 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14722 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 5 | 1998 | 9274 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 113 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 1991 | 248 | 0.020 |
Why?
|
| Cognition Disorders | 2 | 2009 | 4043 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 596 | 0.020 |
Why?
|
| Affective Disorders, Psychotic | 1 | 1991 | 191 | 0.020 |
Why?
|
| Cognition | 2 | 2008 | 6770 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5097 | 0.020 |
Why?
|
| Organ Size | 1 | 1994 | 2252 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1998 | 2440 | 0.020 |
Why?
|
| Motor Cortex | 2 | 1987 | 986 | 0.020 |
Why?
|
| Age of Onset | 1 | 1995 | 3271 | 0.020 |
Why?
|
| Methaqualone | 1 | 1988 | 4 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 1993 | 748 | 0.020 |
Why?
|
| Dementia | 1 | 1983 | 2518 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 695 | 0.020 |
Why?
|
| Tryptophan Oxygenase | 1 | 1968 | 19 | 0.020 |
Why?
|
| Radiation Effects | 1 | 1968 | 68 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 1785 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5391 | 0.020 |
Why?
|
| Organ Preservation | 1 | 2010 | 331 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 231 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 281 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1996 | 4217 | 0.020 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2009 | 288 | 0.020 |
Why?
|
| Pregnancy | 2 | 2001 | 29144 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12959 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 780 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 981 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2013 | 2634 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 2804 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 8863 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 1681 | 0.020 |
Why?
|
| United States | 4 | 2013 | 69872 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 694 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4161 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 641 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2019 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1997 | 9849 | 0.020 |
Why?
|
| Ion Channels | 1 | 2008 | 1056 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1184 | 0.010 |
Why?
|
| Thiazoles | 1 | 1991 | 1483 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 13881 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1998 | 9146 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 1917 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1801 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 4931 | 0.010 |
Why?
|
| Child Development | 1 | 1994 | 2223 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1989 | 1951 | 0.010 |
Why?
|
| Probability | 1 | 1987 | 2505 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 2571 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1989 | 1826 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 5021 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1988 | 35421 | 0.010 |
Why?
|
| France | 1 | 2002 | 517 | 0.010 |
Why?
|
| Quality of Life | 1 | 2002 | 12804 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9734 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 2 | 1990 | 3587 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 1861 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1978 | 65 | 0.010 |
Why?
|
| Motivation | 1 | 1989 | 1971 | 0.010 |
Why?
|
| Anura | 1 | 1978 | 86 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5882 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6489 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1998 | 91 | 0.010 |
Why?
|
| Dilatation, Pathologic | 2 | 1990 | 520 | 0.010 |
Why?
|
| Attention | 1 | 1989 | 2400 | 0.010 |
Why?
|
| Social Behavior | 1 | 1985 | 1127 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 29063 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1988 | 2921 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1998 | 311 | 0.010 |
Why?
|
| Liver | 1 | 1972 | 7474 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
| Clathrin | 1 | 1998 | 267 | 0.010 |
Why?
|
| Movement | 1 | 1983 | 1471 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1998 | 315 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1998 | 982 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9687 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1978 | 1827 | 0.010 |
Why?
|
| Twins | 1 | 1997 | 339 | 0.010 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 4258 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2002 | 2539 | 0.010 |
Why?
|
| Chickens | 1 | 1977 | 865 | 0.010 |
Why?
|
| Cholesterol | 2 | 1973 | 2917 | 0.010 |
Why?
|
| Education | 1 | 1997 | 543 | 0.010 |
Why?
|
| Mice | 3 | 2013 | 81183 | 0.010 |
Why?
|
| Rest | 1 | 1978 | 901 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 2118 | 0.010 |
Why?
|
| Isoflurophate | 1 | 1972 | 36 | 0.010 |
Why?
|
| Microsomes | 1 | 1973 | 257 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1972 | 54 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1978 | 1767 | 0.010 |
Why?
|
| Glycerophosphates | 1 | 1972 | 48 | 0.010 |
Why?
|
| Glycerides | 1 | 1972 | 71 | 0.010 |
Why?
|
| Coenzyme A | 1 | 1972 | 39 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1973 | 195 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1129 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 3922 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 467 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 1973 | 279 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1973 | 410 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1972 | 402 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1977 | 1144 | 0.010 |
Why?
|
| Environment | 1 | 1997 | 1124 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1974 | 783 | 0.010 |
Why?
|
| Copper | 1 | 1972 | 366 | 0.010 |
Why?
|
| Risk Factors | 1 | 1997 | 72290 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6386 | 0.010 |
Why?
|
| Length of Stay | 1 | 1982 | 6309 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1974 | 669 | 0.010 |
Why?
|
| Euphoria | 1 | 1988 | 67 | 0.000 |
Why?
|
| Ophthalmology | 1 | 1974 | 508 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1968 | 475 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17446 | 0.000 |
Why?
|
| Tryptophan | 1 | 1968 | 478 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1968 | 626 | 0.000 |
Why?
|
| Social Behavior Disorders | 1 | 1985 | 97 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1972 | 1889 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1973 | 3748 | 0.000 |
Why?
|
| Lipids | 1 | 1972 | 3305 | 0.000 |
Why?
|
| Hypnotics and Sedatives | 1 | 1988 | 1162 | 0.000 |
Why?
|
| Parietal Lobe | 1 | 1985 | 838 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1989 | 6993 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1985 | 2418 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1974 | 571 | 0.000 |
Why?
|
| Germany | 1 | 1974 | 862 | 0.000 |
Why?
|
| Information Systems | 1 | 1974 | 410 | 0.000 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1974 | 392 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1990 | 39050 | 0.000 |
Why?
|
| Pattern Recognition, Automated | 1 | 1974 | 1005 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1990 | 77449 | 0.000 |
Why?
|